Radio-resistant mesenchymal stem cells: mechanisms of resistance and potential implications for the clinic

Nils H. Nicolay; Ramon Lopez Perez; Rainer Saffrich; Peter E. Huber

doi:10.18632/oncotarget.4358

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Reviews:

Radio-resistant mesenchymal stem cells: mechanisms of resistance and potential implications for the clinic

Nils H. Nicolay _, Ramon Lopez Perez, Rainer Saffrich and Peter E. Huber

PDF | HTML | How to cite

Oncotarget. 2015; 6:19366-19380. https://doi.org/10.18632/oncotarget.4358

Metrics: PDF 3898 views | HTML 4262 views | ?

Abstract

Nils H. Nicolay1,2,3, Ramon Lopez Perez2,3, Rainer Saffrich4 and Peter E. Huber1,2,3

1 Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany

2 Heidelberg Institute for Radiation Oncology (HIRO), National Center for Radiation Research in Oncology, Heidelberg, Germany

3 Department of Molecular and Radiation Oncology, German Cancer Research Center (dkfz), Heidelberg, Germany

4 Department of Hematology and Oncology, Heidelberg University Hospital, Heidelberg, Germany

Correspondence to:

Nils H. Nicolay, email:

Keywords: mesenchymal stem cell, radiotherapy, double strand break, tissue regeneration

Received: May 17, 2015 Accepted: May 30, 2015 Published: June 08, 2015

Abstract

Mesenchymal stem cells (MSCs) comprise a heterogeneous population of multipotent stromal cells and can be isolated from various tissues and organs. Due to their regenerative potential, they have been subject to intense research efforts, and they may provide an efficient means for treating radiation-induced tissue damage. MSCs are relatively resistant to ionizing radiation and retain their stem cell characteristics even after high radiation doses. The underlying mechanisms for the observed MSC radioresistance have been extensively studied and may involve efficient DNA damage recognition, double strand break repair and evasion of apoptosis. Here, we present a concise review of the published scientific data on the radiobiological features of MSCs. The involvement of different DNA damage recognition and repair pathways in the creation of a radioresistant MSC phenotype is outlined, and the roles of apoptosis, senescence and autophagy regarding the reported radioresistance are summarized. Finally, potential influences of the radioresistant MSCs for the clinic are discussed with respect to the repair and radioprotection of irradiated tissues.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 4358

Publication Alerts

Reviews:

Radio-resistant mesenchymal stem cells: mechanisms of resistance and potential implications for the clinic

Abstract